SHPH Insider Trading

Insider Ownership Percentage: 48.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $9,700.80

Shuttle Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Shuttle Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Shuttle Pharmaceuticals Share Price & Price History

Current Price: $2.03
Price Change: Price Increase of +0.17 (9.14%)
As of 02/1/2023 01:00 AM ET

This chart shows the closing price history over time for SHPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Shuttle Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/29/2022Hoek Michael VanderCFOSell2,243$1.60$3,588.803,852View SEC Filing Icon  
12/29/2022Peter DritschiloCOOSell3,820$1.60$6,112.006,560View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Shuttle Pharmaceuticals (NASDAQ:SHPH)

3.79% of Shuttle Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SHPH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Shuttle Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2022Jane Street Group LLC20,968$96K0.0%N/A0.158%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP32,808$0.15M0.0%N/A0.247%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.308,137$1.41M0.0%N/A2.320%Search for SEC Filing on Google Icon
11/14/2022Hsbc Holdings PLC13,737$67K0.0%N/A0.103%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG33,950$0.16M0.0%N/A0.256%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC17,048$78K0.0%N/A0.128%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Shuttle Pharmaceuticals logo
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Read More on Shuttle Pharmaceuticals

Today's Range

Now: $2.03
Low: $1.88
High: $2.13

50 Day Range

MA: $2.11
Low: $1.45
High: $3.00

52 Week Range

Now: $2.03
Low: $1.35
High: $126.26

Volume

213,802 shs

Average Volume

1,156,468 shs

Market Capitalization

$27.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals' top insider shareholders include:
  1. Peter Dritschilo (COO)
  2. Hoek Michael Vander (CFO)
Learn More about top insider investors at Shuttle Pharmaceuticals.